Find a Doctor:   

      Search
Home | Doctors | Dr G Ranga Raman


About Doctor:

Dr G Ranga Raman is a Senior Consultant at the Department of Medical Oncology at MCI Nellore. He has been contributing to the field of Medical Oncology for over a decade. He was the head of the Medical Oncology department at HCG Cancer Center, Vijayawada for six years. His areas of Immuno oncology, Gastrointestinal (GI) oncology, Breast oncology, Head and Neck Oncology. He has an immense interest in Oncology research & gained insights into oncology research at Royal Adelaide Hospital (RAH), Adelaide, Australia, under the mentorship of Professor Tim Hughes & also served as the principal investigator for various International and National clinical trials.

Languages:

English, Telugu, Hindi

Specialized Area:

  • Chemotherapy
  • Targeted therapy Immunotherapy
  • Colon & GI Cancer
  • Kidney & GU Cancer
  • Breast Cancer Treatment
  • Lung cancer
  • Leukemia
  • Lymphoma
  • Myeloma
  • Pediatric oncology
  • Cancer Screening
  • Ovary Cancer
  • Bone Cancer
  • Thyroid Cancer Palliative treatment Transplant

Past Experience:

  • SGPGI : Hematology; PDT(2010 - 2010)
  • NRSMCH: Hematology; PDT (2011 - 2011)
  • BIACRI: Medical Oncology ; Jr. Consultant (2012-2012)
  • NIMS Medical Oncology ; DM Resident (2013-2015)
  • HCG Curie Cancer Centre: Medical Oncology ; Head of Department (2015-2021)
  • Medicover Cancer Institute: Medical Oncology; Senoir Consultant (2021- to present)

Publications:

  • Outcomes in pediatric CML in a developing country – Beyond the disease biology”. journal of Clinical oncology 32,2014, no.15_suppl e21005 .
  • Prognostic significance of NLR kinetics in operable triple negative breast cancer. e14201 journal of Clinical oncology 37,2019, no.15_suppl.
  • Cytogenetic and molecular response rates in AYA CML CP patients on imatinib based on the baseline BMI”, Annals of Oncology, Volume 27, Issue suppl_9, December 2016, mdw586.009,
  • Is rituximab-based chemotherapy a standard practice in the treatment of B-NHLs in the developing world. journal of Clinical oncology 31,2013_suppl e19533
  • Secondary malignancies in CML patients: a retrospective analysis from tertiary care center in India” Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Page ix92,
Second Opinion
WhatsApp
Book Now